Wynngate Corporation offers quality solutions by bringing FDA and industry expertise to worldwide clients.
About Company
Company Profile:
Wynngate Corporation (aka Wynngate Consulting) was founded in 2024 by Binh Nguyen, Pharm.D., M.S., BCSCP, FHPE, following over 20 years of distinguished service with the USFDA and UCI Health Hospital as a pharmacist, and tenure with Parenteral Drug Association.
Our Vision
To provide comprehensive, high-quality regulatory and compliance solutions to the bio/pharmaceutical, medical device, combination product, dietary supplements, cosmetics, and foods industries. We ensure that safe, effective products successfully navigate global supply chains and remain continuously available to patients in the United States and around the world.
Areas of Expertise
Wynngate Consulting is dedicated to helping life science companies overcome their most complex regulatory challenges, bridging the gap between local manufacturing compliance and global distribution.
Our core services include:
-
Regulatory & Compliance Responses: Expert guidance on FDA-483 observations, Untitled Letters, Warning Letters, and comprehensive remediation strategies.
-
Audit Readiness & Quality Assurance: Execution of rigorous FDA mock audits, internal audits, and the development of sustainable corrective and preventive actions (CAPA).
-
Global Operations Support: Specialized oversight for import/export operations, ensuring seamless international logistics compliance, custom clearance readiness, and foreign facility alignment with USFDA expectations.
-
Quality System Training: Tailored training programs for multiple FDA regulated commodities.
** Wynngate Advantage:** By combining decades of regulatory insider knowledge with a deep understanding of global trade operations, we help safeguard your product quality from the manufacturing floor to international borders.
WYNNGATE CONSULTING
About Leadership
Executive Profile:
Binh Nguyen, Pharm.D., M.S., BCSCP, FHPE
Founder & President, Wynngate Corporation: Dr. Binh Nguyen is a distinguished regulatory expert with over two decades of foundational experience spanning the U.S. Food and Drug Administration (FDA), hospital healthcare systems, and top-tier life science consulting. He specializes in transforming complex compliance and international supply chain challenges into seamless, audit-ready operational strategies.
FDA Leadership & Regulatory Expertise
Dr. Nguyen retired from the FDA in March 2023 after 20 years of dedicated service across the Center for Drug Evaluation and Research (CDER) and the Office of Inspections and Investigations (OII). His career focused on bio/pharmaceutical and combination products training, compliance enforcement, management, and complex international inspections. His credentials and roles included:
-
Elite Inspectorate Status: Served as an FDA Level III Certified Pharmaceutical Inspectorate and Level II Drug Auditor.
-
Regulatory Leadership: Held vital roles as Drug Branch Chief and Director Regulatory Review Officer.
-
Multidisciplinary Scope: Directed oversight for complex product lines including biotechnology, sterile injectables, sterile compounding, Positron Emission Tomography (PET), combination products, and advanced dosage forms.
-
Global Enforcement: Managed critical import/export operations, border compliance, and foreign facility alignment with USFDA expectations.
Clinical & Advisory Foundation
Complementing his regulatory tenure, Dr. Nguyen possesses deep, hands-on clinical and operational experience:
-
UCI Health: Dedicated 21 years as a clinical and compounding pharmacist at UCI Hospital, a premier 400-bed acute care facility.
-
Board of Pharmacy Specialties (BPS): Served a 3-year term as an appointed Council Member for Sterile Compounding Pharmacy.
-
University of Southern California (USC) Regulatory Science Program: CGMP Instructor since 2016
-
Parenteral Drug Association (PDA): Course Builder and Instructor since 2024
Education & Innovation
-
Academic Credentials: Earned both his Doctorate in Pharmacy (Pharm.D.) and Master of Science in Regulatory Science from the University of Southern California (USC).
-
Digital Innovation: Founder and developer of ieQip® (Intelligent Electronic Quality Inspection Platform), a cutting-edge, AI-driven global inspection software used by companies worldwide for independent third-party assessments and internal quality audits.
Consulting Strategy
Following his FDA career, Dr. Nguyen consulted for Lachman Consultants before launching Wynngate Corporation in March 2024 to provide elite, insider-driven compliance architecture to the global life sciences industry.
About Our Team
At Wynngate Corporation, our team bridges the gap between complex federal regulations and operational excellence. Led by former USFDA leaders, credentialed inspectors, and seasoned life science professionals, we deliver elite compliance architecture, enforcement defense, and global supply chain solutions.
Our multidisciplinary expertise spans pharmaceuticals, medical devices, combination products, cosmetics, and advanced food/supplement safety systems.
📋 Global Quality Systems & Remediation
We design, implement, and optimize Quality Management Systems (QMS) that withstand the most rigorous regulatory scrutiny:
-
SOP & QMS Infrastructure: End-to-end SOP Development and Quality Management Systems tailored to your specific operational scale.
-
Corrective Actions: Advanced CAPA, Root Cause Analysis, & Risk Management frameworks.
-
Inspection Readiness: High-fidelity Mock FDA Inspection Delivery to identify vulnerabilities before investigators arrive.
-
Supply Chain Security: Rigorous Supplier Qualification & Verification programs to ensure third-party compliance.
-
Workforce Development: Customized Regulatory Training Development & Delivery to foster a culture of compliance.
🛡️ FDA Import Compliance & Enforcement Defense
Navigating international borders requires absolute regulatory alignment. Our team specializes in securing global supply chains and defending operations against adverse agency actions:
-
Import/Export Operations: Total oversight of FDA Import Compliance and foreign facility readiness to minimize border delays and customs hold-ups.
-
Enforcement Mitigation: Strategic development of Form 483 & Warning Letter Responses, crisis management, and robust Enforcement Action Development.
-
Legal Coordination: Expert partnership in Legal Coordination & Evidence Development to protect your business during complex regulatory disputes.
-
Crisis Control: Rapid-response Recall & Crisis Management to safeguard public health and company reputation.
🍎 Food Safety & Dietary Supplement Compliance (FSMA)
Our team provides comprehensive technical oversight to ensure strict adherence to modernized food safety laws and manufacturing regulations:
-
CGMP Compliance: Deep technical expertise in 21 CFR 111 (Dietary Supplements), 21 CFR 117 (Human Food), and 21 CFR 507 (Animal Food).
-
FSMA Implementation: Full-scale implementation of the Food Safety Modernization Act, including Preventive Controls (PC), Foreign Supplier Verification Programs (FSVP), and Produce Safety rules.
-
Program Design: Direct execution of FSVP Program Design & Qualified Individual (QI) Services.
-
Preventive Architecture: Hazard Analysis, HACCP, and Preventive Controls development.
-
Strategic Auditing: Food Safety Plan Development & Gap Assessments to ensure zero blind spots.
The Wynngate Promise: Whether you are launching a novel pharmaceutical, exporting dietary supplements globally, or responding to an urgent FDA Warning Letter, our team provides the insider knowledge and technical precision required to succeed.
